Filing Details

Accession Number:
0001209191-16-152165
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-28 16:04:08
Reporting Period:
2016-11-23
Filing Date:
2016-11-28
Accepted Time:
2016-11-28 16:04:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1651308 Beigene Ltd. BGNE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1662982 Xiaodong Wang C/O Mourant Ozannes Corporate Services
94 Solaris Avenue
Camana Bay Cayman Islands E9 KY1-1108
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
American Depositary Shares Disposition 2016-11-23 93,750 $32.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 15,125,393 Direct
Ordinary Shares 214,531 Indirect See Footnote
Footnotes
  1. Each American Depositary Share represents 13 Ordinary Shares.
  2. The sale transaction reported on this Form 4 was effected as part of an underwritten public offering of Ordinary Shares in the form of American Depositary Shares of the Company in which the Reporting Person was a selling shareholder.
  3. These securities are held in a UTMA account for Reporting Person's minor child, for which Reporting Person disclaims beneficial ownership.